[en] Acute tubular necrosis induced by aminoglycoside antibiotics and various other nephrotoxins is followed by a regenerative process which leads to the restoration of damaged tubules. Several lines of evidence indicate that tubular regeneration is mediated by polypeptide growth factors such as epidermal growth factor (EGF). Previous studies devoted to cisplatin nephrotoxicity have shown that this agent causes tubular cystic degeneration possibly related to an impairment of renal tissue repair. Thus, we examined on a comparative basis the time course of the regenerative response subsequent to tubular damage induced by tobramycin or cisplatin, particular attention being paid to renal EGF and its receptor. Female Sprague-Dawley rats (160-180 g body weight) were treated during 4 consecutive days with daily doses of 200 mg/kg tobramycin i.p. (BID) or 2 mg/kg cisplatin (once a day). Sham-treated rats were given 0.9% NaCl i.p. following the same protocol. Groups of experimental animals (n = 5-10) were terminated at increasing time intervals (1, 4, 7, 14, 21, 60 days) after cessation of treatment. One hour prior to sacrifice, each individual received i.p. 200 mg/kg 5-bromo-2'-deoxyuridine (BrdU) for the immunohistochemical demonstration of cell proliferation. Blood was collected at the time of sacrifice in order to assess glomerular filtration rate by measuring serum creatinine and BUN levels. Kidneys were analyzed with respect to total EGF determined by RIA in renal tissue homogenates, and soluble EGF was assayed in extracts prepared by centrifugation. Renal tissue was processed for the immunohistochemical detection of S-phase cells, of EGF, of EGF receptors, and of the intermediate filament vimentin, the latter being used as a marker of epithelium dedifferentiation. In absence of nephrotoxic alterations, EGF was immunolocalized in distal tubules, whereas EGF receptor immunostaining was seen in proximal tubules cells. Vimentin immunostaining was confined to glomeruli and blood vessels. Tobramycin and cisplatin caused acute tubular necrosis in proximal convoluted tubules and proximal straight tubules, respectively. Tissue damage was accompanied by renal dysfunction reflected by an elevation of serum creatinine and BUN levels. Tubular necrosis was followed by a proliferative response indicative of tubular regeneration. Regenerative hyperplasia was associated with a reduction of total immunoreactive EGF due to a decrease of tissue-bound proEGF. Tubules undergoing regenerative repair were characterized by a disappearance of EGF receptors and the presence of immunoreactive vimentin. In tobramycin-treated rats, renal dysfunction lasted for 4-7 days and was fully reversible, as indicated by the return of serum markers to normal values.
Walker R.J., Duggin G.G. (1988) Drug nephrotoxicity. Ann Rev Pharmacol Toxicol 28:331-345.
Litterst C.L., Weiss R.B. (1987) Clinical and experimental nephrotoxicity of cancer chemotherapeutic agents. Nephrotoxicity in the Experimental and Clinical Situation , P H Back E A Lock. Martinus Nijhoff Publishers Dordrecht; 771-816.
Tulkens P.M. (1989) Nephrotoxicity of aminoglycoside antibiotics. Toxicol Lett 46:107-123.
Vaamonde C.A. (1984) Antibiotic-induced nephrotoxicity., Nephrology Vol 1, Proceedings of the 9th International Congress of Nephrology, Los Angeles. R R Robinson. Springer-Verlag New York; 844-868.
Mathews A., Bailie G.R. (1987) Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services. J Clin Pharm Ther 12:273-291.
Nonclercq D., Wrona S., Toubeau G., Zanen J., Heuson-Stiennon J.A., Schaudies R.P., Laurent G. (1992) Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study. Renal Failure 14:507-521.
Dentino M., Luft F.C., Yum M.N., Williams S.D., Einhorn L.H. (1978) Long-term effects of cis-diamminedichloride platinum (CDDP) on renal structure and function in man. Cancer 41:1274-1281.
Roth B.J., Einhorn L.H., Greist A. (1988) Long-term complications of cisplatin-based chemotherapy for testis cancer. Semin Oncol 15:345-350.
Daugaard G., Abildgaard U. (1989) Cisplatin nephrotoxicity. Cancer Chemother Pharmacol 25:1-9.
Gouge S.F., Tietjen D.P., Moore J. (1989) Irreversible renal failure after intraperitoneal cisplatin administration. J Reprod Med 34:931-933.
Hacker M.P. (1991) Toxicity of platinum-based anticancer drugs. The Toxicity of Anticancer Drugs , G Powis M R Hacker. Pergamon Press New York; 82-105.
Bianchetti M.G., Kanaka C., Ridolfi-Lüthy A., Hirt A., Wagner A.P., Oetliker O.H. (1991) Persisting renotubular sequelae after cisplatin in children and adolescents. Am J Nephrol 11:127-130.
Dobyan D.C., Hill D., Lewis T., Bulger R.E. (1981) Cyst formation in rat kidney induced by cis-platinum administration. Lab Invest 45:260-268.
Dobyan D.C. (1985) Long-term consequences of cisplatinum-induced renal injury: a structural and functional study. Anat Rec 212:239-245.
Laurent G., Yernaux V., Nonclercq D., Toubeau G., Maldague P., Tulkens P.M., Heuson-Stiennon J.A. (1988) Tissue injury and proliferative response induced in rat kidney by cis-diamminedichloroplatinum (II). Virchows Arch B—Cell Pathol 55:129-145.
Nonclercq D., Toubeau G., Laurent G., Tulkens P.M., Heuson-Stiennon J.A. (1989) Tissue injury and repair in the rat kidney after exposure to cisplatin and carboplatin. Exp Mol Pathol 51:123-140.
Segal R., Fine L.G. (1989) Polypeptide growth factors and the kidney. Kidney Int 36(27):S2-10.
Hammerman M.R., Oshea M., Miller S.B. (1993) Role of growth factors in regulation of renal growth. Ann Rev Physiol 55:305-321.
Humes H.D., Cieslinski D.A., Coimbra T.M., Messana J.M., Galvao C. (1989) Epidermal growth factor enhances renal tubule cell regeneration and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757-1761.
Norman J., Tsau Y.K., Bacay A., Fine L.G. (1990) Epidermal growth factor accelerates functional recovery from ischemic acute tubular necrosis in the rat: role of the epidermal growth factor receptor. Clin Sci (Lond) 78:445-450.
Alberti P., Bardella L., Comolli R. (1992) Ribosomal protein S6 kinase is; activated after folic acid injury and epidermal growth factor administration but not after unilateral nephrectomy in the rat kidney. Nephron 60:330-335.
Morin N.J., Laurent G., Nonclercq D., Toubeau G., Heuson-Stiennon J.A., Bergeron M.G., Beauchamp D. (1992) Epidermal growth factor (EGF) accelerates renal tissue repair in a rat model of gentamicin nephrotoxicity. Am J Physiol 263:F806-F811.
Miller S.B., Martin D.R., Kissane J., Hammerman M.R. (1993) Insulin-like growth factor-1 accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880.
Schaudies R.P., Johnson J.P. (1993) Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors. Am J Physiol 264:F523-F531.
Schaudies R.P., Nonclercq D., Nelson L., Toubeau G., Zanen J., Heuson-Stiennon J.A., Laurent G. (1993) Endogenous EGF as a potential renotrophic factor in ischemia induced acute renal failure. Am J Physiol 265:F425-F434.
Toubeau J., Nonclercq D., Zanen J., Laurent G., Schaudies P., Heuson-Stiennon J.A. (1994) Renal tissue expression of EGF and of EGF receptor after ischemic tubular injury: an immunohistochemical study. Exp Nephrol 2:229-239.
Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
Kris R.M., Lax I., Gullick W., Waterfield M.D., Ullrich A., Fridkin M., Schlessinger J. (1985) Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell 40:619-625.
Nilaver G., Kozlowski G.P. (1989) Comparison of the PAP and ABC immunocytochemical techniques. Techniques in Immunocytochemistry , G R Bullock P Petrusz. Academic Press London; 4:199-215.
Schaudies R.P., Savage C.R. (1986) Isolation of rat epidermal growth factor (r-EGF): chemical, biological and immunological comparisons with mouse and human EGF. Comp Biochem Physiol 848:497-505.
Axen R., Porath J., Ernbach S. (1967) Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 214:1302-1304.
Salido E.C., Lakshmanan J., Fisher D.A., Shapiro L.J., Barajas L. (1991) Expression of epidermal growth factor in the rat kidney. Histochemistry 96:65-72.
Laurent G., Toubeau G., Heuson-Stiennon J.A., Tulkens P., Maldague P. (1988) Kidney tissue repair after nephrotoxic injury: biochemical and morphological characterization. CRC Crit Rex Toxicol 19:147-183.
Toback F.G. (1992) Regeneration after acute tubular necrosis. Kidney Int 41:226-246.
Safirstein R., Winston J., Moel D., Dikman S., Guttenplan J. (1987) Cisplatin nephrotoxicity: insights into mechanisms. Int J Androl 10:325-346.
Cuppage F.E., Tate A. (1967) Repair of the nephron following injury with mercuric chloride. Am J Pathol 51:405-429.
Norman J.T., Bohman R.E., Fischmann G., Bowen J.W., McDonough A., Slamon D., Fine L.G. (1988) Patterns of mRNA expression during early cell growth differ in kidney epithelial cells destined to undergo compensatory hypertrophy versus regenerative hyperplasia. Proc Natl Acad Sci USA 85:6768-6772.
Cowley B., Chadwick L., Grantham J., Calvet J. (1989) Sequential protooncogene expression in regenerating kidney following acute renal injury. J Biol Chem 264:8389-8393.
Norman J., Badie-Dezfooly B., Nord E.P., Kurtz I., Schlosser J., Chaudhari A., Fine L.G. (1987) EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 253:F299-F309.
Goodyer P.R., Kachra Z., Bell C., Rozen R. (1988) Renal tubular cells are potential targets for epidermal growth factor. Am J Physiol 255:F1191-F1196.
Humes H.D., Beals T.F., Cieslinski D.A., Sanchez I.O., Page T.P. (1991) Effects of transforming growth factor-β, transforming growth factor-α, and other growth factors on renal proximal tubule cells. Lab Invest 64:538-545.
Safirstein R., Zelent A.Z., Price P.M. (1989) Reduced renal prepro-epidermal growth factor messenger RNA and decreased EGF excretion in ARE. Kidney Int 36:810-815.
Safirstein R., Price P.M., Saggi S.J., Harris R.C. (1990) Changes in gene expression after temporary renal ischemia. Kidney Int 37:1515-1521.
Verstrepen W.A., Nouwen E.J., Yue X.S., De Broe M.E. (1993) Altered growth factor expression during toxic proximal tubular necrosis and regeneration. Kidney Int 43:1267-1279.
Taira T., Yoshimura A., Inui K., Oshiden K., Ideura T., Koshikawa S., Solez K. (1994) Immunochemical study of epidermal growth factor in rats with mercuric chloride-induced acute renal failure. Nephron 67:88-93.
Matejka G.L., Jennische E. (1992) IGF-I binding and IGF-I mRNA expression in the post-ischemic regenerating rat kidney. Kidney Int 42:1113-1123.
Igawa T., Matsumoto K., Kanda S., Saito Y., Nakamura T. (1993) Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 265:F61-F69.
Zhang G., Ichimura T., Maier J.A.M., Maciag T., Stevens J.L. (1993) A role for fibroblastic growth factor type-1 in nephrogenic repair: autocrine expression in rat kidney proximal tubule epithelial cells in vitro and in the regenerating epithelium following nephrotoxic damage by S-(1,1,2,2-tetrafluoroethyl)- L-cysteine in vivo. J Biol Chem 268:11542-11547.
Harris R.C., Daniel T.O. (1989) Epidermal growth factor binding stimulation of phosphorylation and inhibition of gluconeogenesis in rat proximal tubule. J Cell Physiol 139:383-391.
Behrens M.T., Corbin A.L., Hise M.K. (1989) Epidermal growth factor receptor regulation in rat kidney: two models of renal growth. Am J Physiol 257:F1059-F1064.
Breyer M.D., Redha R., Breyer J.A. (1990) Segmental distribution of epidermal growth factor binding sites in rabbit nephron. Am J Physiol 259:F553-F558.
Antonipillai I. (1993) Epidermal growth factor is a potent inhibitor of renin secretion. Hypertension 21:654-659.
Dunn W.A., Connolly T.P., Hubbard A.L. (1986) Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway. J Cell Biol 102:24-36.
Renfrew C.A., Hubbard A.L. (1991) Degradation of epidermal growth factor receptor in rat liver: membrane topology through the lysosomal pathway. J Biol Chem 266:21265-21273.
Wallin A., Zhang G., Jones T.W., Jaken S., Stevens J.L. (1992) Mechanism of the nephrogenic repair response: studies on proliferation and vimentin expression after 35S-1,2-dichlorovinyl- L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab Invest 66:474-484.
Gattone V.H., Andrews G.K., Fu-Wen N., Chadwick L.J., Klein R.M., Calvet J.P. (1990) Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev Biol 138:225-230.
Nakamura T., Ebihara I., Nagaoka I., Tomino Y., Nagao S., Takahashi H., Koide H. (1993) Growth factor gene expression in kidney of murine polycystic kidney disease. J Am Soc Nephrol 3:1378-1386.
Safirstein R., Zelent A.Z., Gordon R. (1988) Cisplatin nephrotoxicity: new insights into mechanism. Organ Directed Toxicities of Anticancer Drugs , T R Tritton. Martinus Nijhoff Boston; 172-189.